DEL Bulletin – Letter to market authorization holders of human pharmaceutical products to inform on steps to take to avoid nitrosamine impurities

Posted Date: 8-October-2019

FDA Issues FY2023 Report on the State of Pharmaceutical Quality

Posted By:  Linitha Ganesh

Please login to view this content.